chikungunya vaccine

The Austrian biotech company Themis Bioscience GmbH in collaboration with  the Institut Pasteur (Paris, France) has developed a prophylactic vaccine against chikungunya. The vaccine appears to be safe, and produced an immune response …
Read More...